TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
A Detailed Look at My Top Stock Pick for November
Investing
Manitoba’s Plans for Marijuana Could Create Significant Growth Opportunities
Dividend Stocks
5 Non-Cannabis Stocks That Have High Growth and Pay Dividends
Investing
Reviewing My Pick of the Month for October
Investing
TSX Reaches 16,000: These Are 5 of the Highest-Performing Stocks This Year
Investing
Canopy Growth Corp. Surges 14.4% in a Day: Could Shares Hit $25 Before Year’s End?
Investing
Which WEED Manufacturer Gets Next Big Cheque?
Investing
The Fastest Road to Millionaire Status: Growth or Value?
Investing
Can Any Other Cannabis Stock Measure Up to Canopy Growth Corp. Right Now?
Investing
Why Canopy Growth Corp. Is up Over 25% This Week